Who to call at Ray Therapeutics, and when
Fundz watches for the moments Ray Therapeutics starts buying, and tells you who to reach.
- An alert the day Ray Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ray Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ray Therapeutics. With Fundz connected, it knows.
Ray Therapeutics receives $8M grant from CIRM to advance optogenetic gene therapy for Stargardt disease.
Description
Ray Therapeutics, a Berkeley-based biopharmaceutical company, received an $8 million grant from the California Institute for Regenerative Medicine (CIRM). The funds will support advancement of the Phase 1/2 clinical trial and manufacturing activities for RTx-021, an optogenetic gene therapy designed to restore vision in patients with Stargardt disease. Ray Therapeutics develops bioengineered, light-sensitive proteins delivered via intravitreal injection to improve visual function in retinal degenerative diseases. The company is led by CEO Paul Bresge.
Quick answer
Ray Therapeutics receives $8M grant from CIRM to advance optogenetic gene therapy for Stargardt disease. (October 1, 2026). Ray Therapeutics is based in San Diego, California, United States.
- What agreement did Ray Therapeutics announce on October 1, 2026?
- Ray Therapeutics, a Berkeley-based biopharmaceutical company, received an $8 million grant from the California Institute for Regenerative Medicine (CIRM). The funds will support advancement of the Phase 1/2 clinical trial and manufacturing activities for RTx-021, an optogenetic gene therapy designed to restore vision in patients with Stargardt disease.
- What does Ray Therapeutics do?
- Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and...
- Where is Ray Therapeutics based?
- Ray Therapeutics is based in San Diego, California, United States.
- Which similar companies announced agreements around the same time?
- Lynk Pharmaceuticals (November 3, 2026), IgniteData (October 15, 2026), NeOnc Technologies (October 16, 2026) and Danaher (October 18, 2026) also announced agreements within 45 days of Ray Therapeutics.
Source: Fundz verified event record.
Other recent agreements in Science And Engineering and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Lynk Pharmaceuticals and Simcere Expand Partnership for Zemprocitinib Commercialization in Greater China. (November 3, 2026)
- IgniteData and RealTime eClinical Solutions Partner to Enhance Clinical Data Transfer. (October 15, 2026)
- NeOnc Technologies Signs MoU with Abu Dhabi Department of Health (October 16, 2026)
- Danaher and NVIDIA Partner to Advance Autonomous Science Through AI Technology. (October 18, 2026)
- Encare AB Signs Agreement with National Cancer Institute of Thailand to Enhance Surgical Care. (October 18, 2026)
- Penelope Bourbon Partners with FCancer to Celebrate Fifth Anniversary with $250,000 Commitment. (October 19, 2026)
Related People
Ray Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.